Adaptive Licensing

On 2 June 2014, the ABPI, the BioIndustry Association (BIA) and the Centre for the Advancement of Sustainable Medical Innovation (CASMI) jointly organised a stakeholder event in London to publicise the EMA’s Adaptive Licensing pilot project. This workshop allowed pharmaceutical and biotech companies, as well as patient groups, to understand better which medicines would be appropriate to put forward for the Adaptive Licensing pilot and to appreciate how the pilot would work in practice.